A key theme emerging from FDA complete response letters since 2018 is that data system validation is lacking in the biomanufacturing sector.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.